NEW YORK, July 29, 2019 /PRNewswire/ --
Vaccine Adjuvants market worldwide is projected to grow by US$516.
85 Thousand, guided by a compounded growth of 10.6%. Staying on top of trends is essential for decision makers to leverage this emerging opportunity. The report addresses this very need and provides the latest scoop on all major market segments. Particulate Adjuvants, one of the segments analyzed and sized in this study, displays the potential to grow at over 10.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$304.8 Thousand by the year 2025, Particulate Adjuvants will bring in healthy gains adding significant momentum to global growth.
Download the full report: https://www.reportbuyer.com/product/5799883/?utm_source=PRN
- While global megatrends sweeping through the market influence the primary direction of growth, regional markets are swayed by more granular locally unique business drivers. Representing the developed world, the United States will maintain a 12.9% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$39.4 Thousand to the region's size and clout in the next 5 to 6 yearsOver US$49.7 Thousand worth of projected demand in the region will come from other emerging Eastern European markets. In Japan, Particulate Adjuvants will reach a market size of US$21.6 Thousand by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 9.9% over the next couple of years and add approximately US$85.7 Thousand in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
- Competitors identified in this market include among others, Agenus, Inc. (USA); Avanti Polar Lipids, Inc. (USA); Brenntag Biosector A/S (Denmark); CSL Ltd. (Australia); Invivogen (USA); Mvp Laboratories Inc. (USA); Novavax, Inc. (USA); OZ Biosciences SAS (France); Seppic SA (France); SPI Pharma (USA)
Download the full report: https://www.reportbuyer.com/product/5799883/?utm_source=PRN
VACCINE ADJUVANTS MARKET ANALYSIS, TRENDS, AND FORECASTS, JULY 2019
CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Vaccine Adjuvants Competitor Market Share Scenario Worldwide
(in %): 2019 & 2025
Global Competitor Market Shares by Segment
Particulate Adjuvants (Type) Global Competitor Market Share
Positioning for 2019 & 2025
Adjuvant Emulsions (Type) Market Share Breakdown of Key
Players: 2019 & 2025
Pathogen Components (Type) Competitor Revenue Share (in %):
2019 & 2025
Combination Adjuvants (Type) Market Share Shift by Company:
2019 & 2025
Subcutaneous (Route Of Administration) Global Competitor Market
Share Positioning for 2019 & 2025
Intramuscular (Route Of Administration) Market Share Breakdown
of Key Players: 2019 & 2025
Intranasal Route (Route Of Administration) Competitor Revenue
Share (in %): 2019 & 2025
Oral Route (Route Of Administration) Market Share Shift by
Company: 2019 & 2025
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Vaccine Adjuvants Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Vaccine Adjuvants Global Retrospective Market Scenario
in US$ Million by Region/Country: 2009-2017
Table 3: Vaccine Adjuvants Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Research (Application) Worldwide Sales in US$ Million
by Region/Country: 2018-2025
Table 5: Research (Application) Historic Demand Patterns in US$
Million by Region/Country: 2009-2017
Table 6: Research (Application) Market Share Shift across Key
Geographies: 2009 VS 2019 VS 2025
Table 7: Commercial (Application) Global Market Estimates &
Forecasts in US$ Million by Region/Country: 2018-2025
Table 8: Commercial (Application) Retrospective Demand Analysis
in US$ Million by Region/Country: 2009-2017
Table 9: Commercial (Application) Market Share Breakdown by
Region/Country: 2009 VS 2019 VS 2025
Table 10: Particulate Adjuvants (Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 11: Particulate Adjuvants (Type) Historic Market Analysis
by Region/Country in US$ Million: 2009 to 2017
Table 12: Particulate Adjuvants (Type) Market Share Breakdown
of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 13: Adjuvant Emulsions (Type) Potential Growth Markets
Worldwide in US$ Million: 2018 to 2025
Table 14: Adjuvant Emulsions (Type) Historic Market Perspective
by Region/Country in US$ Million: 2009 to 2017
Table 15: Adjuvant Emulsions (Type) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 16: Pathogen Components (Type) Geographic Market Spread
Worldwide in US$ Million: 2018 to 2025
Table 17: Pathogen Components (Type) Region Wise Breakdown of
Global Historic Demand in US$ Million: 2009 to 2017
Table 18: Pathogen Components (Type) Market Share Distribution
in Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 19: Combination Adjuvants (Type) World Market Estimates
and Forecasts by Region/Country in US$ Million: 2018 to 2025
Table 20: Combination Adjuvants (Type) Market Historic Review
by Region/Country in US$ Million: 2009 to 2017
Table 21: Combination Adjuvants (Type) Market Share Breakdown
by Region/Country: 2009 VS 2019 VS 2025
Table 22: Other Types (Type) World Market by Region/Country in
US$ Million: 2018 to 2025
Table 23: Other Types (Type) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 24: Other Types (Type) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 25: Infectious Diseases (Disease Type) World Market
Estimates and Forecasts by Region/Country in US$ Million: 2018
to 2025
Table 26: Infectious Diseases (Disease Type) Market Historic
Review by Region/Country in US$ Million: 2009 to 2017
Table 27: Infectious Diseases (Disease Type) Market Share
Breakdown by Region/Country: 2009 VS 2019 VS 2025
Table 28: Cancer (Disease Type) World Market by Region/Country
in US$ Million: 2018 to 2025
Table 29: Cancer (Disease Type) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 30: Cancer (Disease Type) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 31: Other Disease Types (Disease Type) World Market
Estimates and Forecasts in US$ Million by Region/Country: 2018
to 2025
Table 32: Other Disease Types (Disease Type) Market Worldwide
Historic Review by Region/Country in US$ Million: 2009 to 2017
Table 33: Other Disease Types (Disease Type) Market Percentage
Share Distribution by Region/Country: 2009 VS 2019 VS 2025
Table 34: Subcutaneous (Route of Administration) World Market
Estimates and Forecasts in US$ Million by Region/Country: 2018
to 2025
Table 35: Subcutaneous (Route of Administration) Market
Worldwide Historic Review by Region/Country in US$ Million:
2009 to 2017
Table 36: Subcutaneous (Route of Administration) Market
Percentage Share Distribution by Region/Country: 2009 VS 2019
VS 2025
Table 37: Intramuscular (Route of Administration) Market
Opportunity Analysis Worldwide in US$ Million by
Region/Country: 2018 to 2025
Table 38: Intramuscular (Route of Administration) Global
Historic Demand in US$ Million by Region/Country: 2009 to 2017
Table 39: Intramuscular (Route of Administration) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 40: Intranasal Route (Route of Administration) World MARKET by Region/Country in US$ Million: 2018 to 2025
Table 41: Intranasal Route (Route of Administration) Historic MARKET Analysis by Region/Country in US$ Million: 2009 to 2017
Table 42: Intranasal Route (Route of Administration) Market
Share Breakdown of Worldwide Sales by Region/Country: 2009 VS
2019 VS 2025
Table 43: Oral Route (Route of Administration) Potential Growth MARKETs Worldwide in US$ Million: 2018 to 2025
Table 44: Oral Route (Route of Administration) Historic Market
Perspective by Region/Country in US$ Million: 2009 to 2017
Table 45: Oral Route (Route of Administration) Market Sales
Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 46: Other Route of Administrations (Route of
Administration) Geographic Market Spread Worldwide in US$
Million: 2018 to 2025
Table 47: Other Route of Administrations (Route of
Administration) Region Wise Breakdown of Global Historic Demand
in US$ Million: 2009 to 2017
Table 48: Other Route of Administrations (Route of
Administration) Market Share Distribution in Percentage by
Region/Country: 2009 VS 2019 VS 2025
Table 49: Human Vaccine Adjuvants (Application Category)
Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
Table 50: Human Vaccine Adjuvants (Application Category)
Historic Market Perspective by Region/Country in US$ Million:
2009 to 2017
Table 51: Human Vaccine Adjuvants (Application Category) Market
Sales Breakdown by Region/Country in Percentage: 2009 VS 2019
VS 2025
Table 52: Veterinary Vaccine Adjuvants (Application Category)
Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
Table 53: Veterinary Vaccine Adjuvants (Application Category)
Region Wise Breakdown of Global Historic Demand in US$ Million:
2009 to 2017
Table 54: Veterinary Vaccine Adjuvants (Application Category) MARKET Share Distribution in Percentage by Region/Country: 2009
VS 2019 VS 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES MARKET Facts & Figures
US Vaccine Adjuvants Market Share (in %) by Company: 2019 & 2025
Particulate Adjuvants (Type) Market Share Analysis (in %) of
Leading Players in the US for 2019 & 2025
Adjuvant Emulsions (Type) Competitor Revenue Share (in %) in
the US: 2019 & 2025
Pathogen Components (Type) Market Share Breakdown (in %) of
Major Players in the US: 2019 & 2025
Combination Adjuvants (Type) Market in the US: Percentage
Breakdown of Revenues by Company for 2019 & 2025
Subcutaneous (Route Of Administration) Competitor Market Share
Breakdown (in %) in the US for 2019 & 2025
Intramuscular (Route Of Administration) Market: Revenue Share
Breakdown (in %) of Key Players in the US: 2019 & 2025
Intranasal Route (Route Of Administration) Market Share
Analysis (in %) of Leading Players in the US for 2019 & 2025
Oral Route (Route Of Administration) Competitor Revenue Share
(in %) in the US: 2019 & 2025
Table 55: United States Vaccine Adjuvants Latent Demand
Forecasts in US$ Million by Application: 2018 to 2025
Table 56: Vaccine Adjuvants Historic Demand Patterns in the
United States by Application in US$ Million for 2009-2017
Table 57: Vaccine Adjuvants Market Share Breakdown in the
United States by Application: 2009 VS 2019 VS 2025
Table 58: United States Vaccine Adjuvants Market Estimates and
Projections in US$ Million by Type: 2018 to 2025
Table 59: Vaccine Adjuvants Market in the United States by
Type: A Historic Review in US$ Million for 2009-2017
Table 60: United States Vaccine Adjuvants Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 61: United States Vaccine Adjuvants Market Estimates and
Projections in US$ Million by Disease Type: 2018 to 2025
Table 62: Vaccine Adjuvants Market in the United States by
Disease Type: A Historic Review in US$ Million for 2009-2017
Table 63: United States Vaccine Adjuvants Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 64: United States Vaccine Adjuvants Market Estimates and
Projections in US$ Million by Route of Administration: 2018 to
2025
Table 65: Vaccine Adjuvants Market in the United States by
Route of Administration: A Historic Review in US$ Million for
2009-2017
Table 66: United States Vaccine Adjuvants Market Share
Breakdown by Route of Administration: 2009 VS 2019 VS 2025
Table 67: United States Vaccine Adjuvants Market Estimates and
Projections in US$ Million by Application Category: 2018 to
2025
Table 68: Vaccine Adjuvants Market in the United States by
Application Category: A Historic Review in US$ Million for
2009-2017
Table 69: United States Vaccine Adjuvants Market Share
Breakdown by Application Category: 2009 VS 2019 VS 2025
CANADA
Table 70: Canadian Vaccine Adjuvants Market Quantitative Demand
Analysis in US$ Million by Application: 2018 to 2025
Table 71: Vaccine Adjuvants Market in Canada: Summarization of
Historic Demand Patterns in US$ Million by Application for
2009-2017
Table 72: Canadian Vaccine Adjuvants Market Share Analysis by
Application: 2009 VS 2019 VS 2025
Table 73: Canadian Vaccine Adjuvants Market Estimates and
Forecasts in US$ Million by Type: 2018 to 2025
Table 74: Canadian Vaccine Adjuvants Historic Market Review by
Type in US$ Million: 2009-2017
Table 75: Vaccine Adjuvants Market in Canada: Percentage Share
Breakdown of Sales by Type for 2009, 2019, and 2025
Table 76: Canadian Vaccine Adjuvants Market Estimates and
Forecasts in US$ Million by Disease Type: 2018 to 2025
Table 77: Canadian Vaccine Adjuvants Historic Market Review by
Disease Type in US$ Million: 2009-2017
Table 78: Vaccine Adjuvants Market in Canada: Percentage Share
Breakdown of Sales by Disease Type for 2009, 2019, and 2025
Table 79: Canadian Vaccine Adjuvants Market Estimates and
Forecasts in US$ Million by Route of Administration: 2018 to
2025
Table 80: Canadian Vaccine Adjuvants Historic Market Review by
Route of Administration in US$ Million: 2009-2017
Table 81: Vaccine Adjuvants Market in Canada: Percentage Share
Breakdown of Sales by Route of Administration for 2009, 2019,
and 2025
Table 82: Canadian Vaccine Adjuvants Market Estimates and
Forecasts in US$ Million by Application Category: 2018 to 2025
Table 83: Canadian Vaccine Adjuvants Historic Market Review by
Application Category in US$ Million: 2009-2017
Table 84: Vaccine Adjuvants Market in Canada: Percentage Share
Breakdown of Sales by Application Category for 2009, 2019, and
2025
JAPAN
Table 85: Japanese Demand Estimates and Forecasts for Vaccine
Adjuvants in US$ Million by Application: 2018 to 2025
Table 86: Japanese Vaccine Adjuvants Market in US$ Million by
Application: 2009-2017
Table 87: Vaccine Adjuvants Market Share Shift in Japan by
Application: 2009 VS 2019 VS 2025
Table 88: Japanese Market for Vaccine Adjuvants: Annual Sales
Estimates and Projections in US$ Million by Type for the period
2018-2025
Table 89: Vaccine Adjuvants Market in Japan: Historic Sales
Analysis in US$ Million by Type for the Period 2009-2017
Table 90: Japanese Vaccine Adjuvants Market Share Analysis by
Type: 2009 VS 2019 VS 2025
Table 91: Japanese Market for Vaccine Adjuvants: Annual Sales
Estimates and Projections in US$ Million by Disease Type for
the period 2018-2025
Table 92: Vaccine Adjuvants Market in Japan: Historic Sales
Analysis in US$ Million by Disease Type for the Period
2009-2017
Table 93: Japanese Vaccine Adjuvants Market Share Analysis by
Disease Type: 2009 VS 2019 VS 2025
Table 94: Japanese Market for Vaccine Adjuvants: Annual Sales
Estimates and Projections in US$ Million by Route of
Administration for the period 2018-2025
Table 95: Vaccine Adjuvants Market in Japan: Historic Sales
Analysis in US$ Million by Route of Administration for the
Period 2009-2017
Table 96: Japanese Vaccine Adjuvants Market Share Analysis by
Route of Administration: 2009 VS 2019 VS 2025
Table 97: Japanese Market for Vaccine Adjuvants: Annual Sales
Estimates and Projections in US$ Million by Application
Category for the period 2018-2025
Table 98: Vaccine Adjuvants Market in Japan: Historic Sales
Analysis in US$ Million by Application Category for the Period
2009-2017
Table 99: Japanese Vaccine Adjuvants Market Share Analysis by
Application Category: 2009 VS 2019 VS 2025
CHINA
Table 100: Chinese Demand for Vaccine Adjuvants in US$ Million
by Application: 2018 to 2025
Table 101: Vaccine Adjuvants Market Review in China in US$
Million by Application: 2009-2017
Table 102: Chinese Vaccine Adjuvants Market Share Breakdown by
Application: 2009 VS 2019 VS 2025
Table 103: Chinese Vaccine Adjuvants Market Growth Prospects in
US$ Million by Type for the Period 2018-2025
Table 104: Vaccine Adjuvants Historic Market Analysis in China
in US$ Million by Type: 2009-2017
Table 105: Chinese Vaccine Adjuvants Market by Type: Percentage
Breakdown of Sales for 2009, 2019, and 2025
Table 106: Chinese Vaccine Adjuvants Market Growth Prospects in
US$ Million by Disease Type for the Period 2018-2025
Table 107: Vaccine Adjuvants Historic Market Analysis in China
in US$ Million by Disease Type: 2009-2017
Table 108: Chinese Vaccine Adjuvants Market by Disease Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 109: Chinese Vaccine Adjuvants Market Growth Prospects in
US$ Million by Route of Administration for the Period 2018-2025
Table 110: Vaccine Adjuvants Historic Market Analysis in China
in US$ Million by Route of Administration: 2009-2017
Table 111: Chinese Vaccine Adjuvants Market by Route of
Administration: Percentage Breakdown of Sales for 2009, 2019,
and 2025
Table 112: Chinese Vaccine Adjuvants Market Growth Prospects in
US$ Million by Application Category for the Period 2018-2025
Table 113: Vaccine Adjuvants Historic Market Analysis in China
in US$ Million by Application Category: 2009-2017
Table 114: Chinese Vaccine Adjuvants Market by Application
Category: Percentage Breakdown of Sales for 2009, 2019, and
2025
EUROPE MARKET Facts & Figures
European Vaccine Adjuvants Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Particulate Adjuvants (Type) Market Share (in %) by Company in
Europe: 2019 & 2025
Adjuvant Emulsions (Type) Market Share (in %) of Major Players
in Europe: 2019 & 2025
Pathogen Components (Type) Competitor Market Share Analysis (in
%) in Europe: 2019 & 2025
Combination Adjuvants (Type) Market in Europe: Competitor
Revenue Share Shift (in %) for 2019 & 2025
Subcutaneous (Route Of Administration) Competitor Market Share
(in %) Positioning in Europe for 2019 & 2025
Intramuscular (Route Of Administration) Key Player Market Share
Breakdown (in %) in Europe: 2019 & 2025
Intranasal Route (Route Of Administration) Market Share (in %)
by Company in Europe: 2019 & 2025
Oral Route (Route Of Administration) Market Share (in %) of
Major Players in Europe: 2019 & 2025
Table 115: European Vaccine Adjuvants Market Demand Scenario in
US$ Million by Region/Country: 2018-2025
Table 116: Vaccine Adjuvants Market in Europe: A Historic MARKET Perspective in US$ Million by Region/Country for the
Period 2009-2017
Table 117: European Vaccine Adjuvants Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 118: European Vaccine Adjuvants Addressable Market
Opportunity in US$ Million by Application: 2018-2025
Table 119: Vaccine Adjuvants Market in Europe: Summarization of
Historic Demand in US$ Million by Application for the Period
2009-2017
Table 120: European Vaccine Adjuvants Market Share Analysis by
Application: 2009 VS 2019 VS 2025
Table 121: European Vaccine Adjuvants Market Estimates and
Forecasts in US$ Million by Type: 2018-2025
Table 122: Vaccine Adjuvants Market in Europe in US$ Million by
Type: A Historic Review for the Period 2009-2017
Table 123: European Vaccine Adjuvants Market Share Breakdown by
Type: 2009 VS 2019 VS 2025
Table 124: European Vaccine Adjuvants Market Estimates and
Forecasts in US$ Million by Disease Type: 2018-2025
Table 125: Vaccine Adjuvants Market in Europe in US$ Million by
Disease Type: A Historic Review for the Period 2009-2017
Table 126: European Vaccine Adjuvants Market Share Breakdown by
Disease Type: 2009 VS 2019 VS 2025
Table 127: European Vaccine Adjuvants Market Estimates and
Forecasts in US$ Million by Route of Administration: 2018-2025
Table 128: Vaccine Adjuvants Market in Europe in US$ Million by
Route of Administration: A Historic Review for the Period
2009-2017
Table 129: European Vaccine Adjuvants Market Share Breakdown by
Route of Administration: 2009 VS 2019 VS 2025
Table 130: European Vaccine Adjuvants Market Estimates and
Forecasts in US$ Million by Application Category: 2018-2025
Table 131: Vaccine Adjuvants Market in Europe in US$ Million by
Application Category: A Historic Review for the Period
2009-2017
Table 132: European Vaccine Adjuvants Market Share Breakdown by
Application Category: 2009 VS 2019 VS 2025
FRANCE
Table 133: Vaccine Adjuvants Quantitative Demand Analysis in
France in US$ Million by Application: 2018-2025
Table 134: French Vaccine Adjuvants Historic Market Review in
US$ Million by Application: 2009-2017
Table 135: French Vaccine Adjuvants Market Share Analysis: A
17-Year Perspective by Application for 2009, 2019, and 2025
Table 136: Vaccine Adjuvants Market in France by Type:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 137: French Vaccine Adjuvants Historic Market Scenario in
US$ Million by Type: 2009-2017
Table 138: French Vaccine Adjuvants Market Share Analysis by
Type: 2009 VS 2019 VS 2025
Table 139: Vaccine Adjuvants Market in France by Disease Type:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 140: French Vaccine Adjuvants Historic Market Scenario in
US$ Million by Disease Type: 2009-2017
Table 141: French Vaccine Adjuvants Market Share Analysis by
Disease Type: 2009 VS 2019 VS 2025
Table 142: Vaccine Adjuvants Market in France by Route of
Administration: Estimates and Projections in US$ Million for
the Period 2018-2025
Table 143: French Vaccine Adjuvants Historic Market Scenario in
US$ Million by Route of Administration: 2009-2017
Table 144: French Vaccine Adjuvants Market Share Analysis by
Route of Administration: 2009 VS 2019 VS 2025
Table 145: Vaccine Adjuvants Market in France by Application
Category: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 146: French Vaccine Adjuvants Historic Market Scenario in
US$ Million by Application Category: 2009-2017
Table 147: French Vaccine Adjuvants Market Share Analysis by
Application Category: 2009 VS 2019 VS 2025
GERMANY
Table 148: Vaccine Adjuvants Market in Germany: Annual Sales
Estimates and Forecasts in US$ Million by Application for the
Period 2018-2025
Table 149: German Vaccine Adjuvants Market in Retrospect in US$
Million by Application: 2009-2017
Table 150: Vaccine Adjuvants Market Share Distribution in
Germany by Application: 2009 VS 2019 VS 2025
Table 151: Vaccine Adjuvants Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Type for the
Period 2018-2025
Table 152: German Vaccine Adjuvants Historic Market Analysis in
US$ Million by Type: 2009-2017
Table 153: German Vaccine Adjuvants Market Share Breakdown by
Type: 2009 VS 2019 VS 2025
Table 154: Vaccine Adjuvants Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Disease Type for
the Period 2018-2025
Table 155: German Vaccine Adjuvants Historic Market Analysis in
US$ Million by Disease Type: 2009-2017
Table 156: German Vaccine Adjuvants Market Share Breakdown by
Disease Type: 2009 VS 2019 VS 2025
Table 157: Vaccine Adjuvants Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Route of
Administration for the Period 2018-2025
Table 158: German Vaccine Adjuvants Historic Market Analysis in
US$ Million by Route of Administration: 2009-2017
Table 159: German Vaccine Adjuvants Market Share Breakdown by
Route of Administration: 2009 VS 2019 VS 2025
Table 160: Vaccine Adjuvants Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Application
Category for the Period 2018-2025
Table 161: German Vaccine Adjuvants Historic Market Analysis in
US$ Million by Application Category: 2009-2017
Table 162: German Vaccine Adjuvants Market Share Breakdown by
Application Category: 2009 VS 2019 VS 2025
ITALY
Table 163: Italian Demand for Vaccine Adjuvants in US$ Million
by Application: 2018 to 2025
Table 164: Vaccine Adjuvants Market Review in Italy in US$
Million by Application: 2009-2017
Table 165: Italian Vaccine Adjuvants Market Share Breakdown by
Application: 2009 VS 2019 VS 2025
Table 166: Italian Vaccine Adjuvants Market Growth Prospects in
US$ Million by Type for the Period 2018-2025
Table 167: Vaccine Adjuvants Historic Market Analysis in Italy
in US$ Million by Type: 2009-2017
Table 168: Italian Vaccine Adjuvants Market by Type: Percentage
Breakdown of Sales for 2009, 2019, and 2025
Table 169: Italian Vaccine Adjuvants Market Growth Prospects in
US$ Million by Disease Type for the Period 2018-2025
Table 170: Vaccine Adjuvants Historic Market Analysis in Italy
in US$ Million by Disease Type: 2009-2017
Table 171: Italian Vaccine Adjuvants Market by Disease Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 172: Italian Vaccine Adjuvants Market Growth Prospects in
US$ Million by Route of Administration for the Period 2018-2025
Table 173: Vaccine Adjuvants Historic Market Analysis in Italy
in US$ Million by Route of Administration: 2009-2017
Table 174: Italian Vaccine Adjuvants Market by Route of
Administration: Percentage Breakdown of Sales for 2009, 2019,
and 2025
Table 175: Italian Vaccine Adjuvants Market Growth Prospects in
US$ Million by Application Category for the Period 2018-2025
Table 176: Vaccine Adjuvants Historic Market Analysis in Italy
in US$ Million by Application Category: 2009-2017
Table 177: Italian Vaccine Adjuvants Market by Application
Category: Percentage Breakdown of Sales for 2009, 2019, and
2025
UNITED KINGDOM
Table 178: United Kingdom Demand Estimates and Forecasts for
Vaccine Adjuvants in US$ Million by Application: 2018 to 2025
Table 179: United Kingdom Vaccine Adjuvants Market in US$
Million by Application: 2009-2017
Table 180: Vaccine Adjuvants Market Share Shift in the United
Kingdom by Application: 2009 VS 2019 VS 2025
Table 181: United Kingdom Market for Vaccine Adjuvants: Annual
Sales Estimates and Projections in US$ Million by Type for the
period 2018-2025
Table 182: Vaccine Adjuvants Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Type for the Period
2009-2017
Table 183: United Kingdom Vaccine Adjuvants Market Share
Analysis by Type: 2009 VS 2019 VS 2025
Table 184: United Kingdom Market for Vaccine Adjuvants: Annual
Sales Estimates and Projections in US$ Million by Disease Type
for the period 2018-2025
Table 185: Vaccine Adjuvants Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Disease Type for the
Period 2009-2017
Table 186: United Kingdom Vaccine Adjuvants Market Share
Analysis by Disease Type: 2009 VS 2019 VS 2025
Table 187: United Kingdom Market for Vaccine Adjuvants: Annual
Sales Estimates and Projections in US$ Million by Route of
Administration for the period 2018-2025
Table 188: Vaccine Adjuvants Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Route of
Administration for the Period 2009-2017
Table 189: United Kingdom Vaccine Adjuvants Market Share
Analysis by Route of Administration: 2009 VS 2019 VS 2025
Table 190: United Kingdom Market for Vaccine Adjuvants: Annual
Sales Estimates and Projections in US$ Million by Application
Category for the period 2018-2025
Table 191: Vaccine Adjuvants Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Application Category
for the Period 2009-2017
Table 192: United Kingdom Vaccine Adjuvants Market Share
Analysis by Application Category: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 193: Rest of Europe Vaccine Adjuvants Addressable Market
Opportunity in US$ Million by Application: 2018-2025
Table 194: Vaccine Adjuvants Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by Application
for the Period 2009-2017
Table 195: Rest of Europe Vaccine Adjuvants Market Share
Analysis by Application: 2009 VS 2019 VS 2025
Table 196: Rest of Europe Vaccine Adjuvants Market Estimates
and Forecasts in US$ Million by Type: 2018-2025
Table 197: Vaccine Adjuvants Market in Rest of Europe in US$
Million by Type: A Historic Review for the Period 2009-2017
Table 198: Rest of Europe Vaccine Adjuvants Market Share
Breakdown by Type: 2009 VS 2019 VS 2025
Table 199: Rest of Europe Vaccine Adjuvants Market Estimates
and Forecasts in US$ Million by Disease Type: 2018-2025
Table 200: Vaccine Adjuvants Market in Rest of Europe in US$
Million by Disease Type: A Historic Review for the Period
2009-2017
Table 201: Rest of Europe Vaccine Adjuvants Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 202: Rest of Europe Vaccine Adjuvants Market Estimates
and Forecasts in US$ Million by Route of Administration:
2018-2025
Table 203: Vaccine Adjuvants Market in Rest of Europe in US$
Million by Route of Administration: A Historic Review for the
Period 2009-2017
Table 204: Rest of Europe Vaccine Adjuvants Market Share
Breakdown by Route of Administration: 2009 VS 2019 VS 2025
Table 205: Rest of Europe Vaccine Adjuvants Market Estimates
and Forecasts in US$ Million by Application Category: 2018-2025
Table 206: Vaccine Adjuvants Market in Rest of Europe in US$
Million by Application Category: A Historic Review for the
Period 2009-2017
Table 207: Rest of Europe Vaccine Adjuvants Market Share
Breakdown by Application Category: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 208: Vaccine Adjuvants Quantitative Demand Analysis in
Asia-Pacific in US$ Million by Application: 2018-2025
Table 209: Asia-Pacific Vaccine Adjuvants Historic Market
Review in US$ Million by Application: 2009-2017
Table 210: Asia-Pacific Vaccine Adjuvants Market Share
Analysis: A 17-Year Perspective by Application for 2009, 2019,
and 2025
Table 211: Vaccine Adjuvants Market in Asia-Pacific by Type:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 212: Asia-Pacific Vaccine Adjuvants Historic Market
Scenario in US$ Million by Type: 2009-2017
Table 213: Asia-Pacific Vaccine Adjuvants Market Share Analysis
by Type: 2009 VS 2019 VS 2025
Table 214: Vaccine Adjuvants Market in Asia-Pacific by Disease
Type: Estimates and Projections in US$ Million for the Period
2018-2025
Table 215: Asia-Pacific Vaccine Adjuvants Historic Market
Scenario in US$ Million by Disease Type: 2009-2017
Table 216: Asia-Pacific Vaccine Adjuvants Market Share Analysis
by Disease Type: 2009 VS 2019 VS 2025
Table 217: Vaccine Adjuvants Market in Asia-Pacific by Route of
Administration: Estimates and Projections in US$ Million for
the Period 2018-2025
Download the full report: https://www.reportbuyer.com/product/5799883/?utm_source=PRN
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com
SOURCE ReportBuyer
![](https://rt.prnewswire.com/rt.gif?NewsItemId=SP26233&Transmission_Id=201907291448PR_NEWS_USPR_____SP26233&DateId=20190729)
Share this article